A randomized trial comparing 4.8 vs. 2.4g/day of oral mesalazine for maintenance of remission in ulcerative colitis
2015 ◽
Vol 47
(11)
◽
pp. 933-937
◽
2005 ◽
Vol 21
(9)
◽
pp. 1111-1119
◽
Keyword(s):
2013 ◽
Vol 19
(8)
◽
pp. 1681-1690
◽
2001 ◽
Vol 120
(5)
◽
pp. A127-A127
◽